Integrated Project Services (IPS)

John J. Gilroy, P.E. has been promoted to general manager, construction at Integrated Project Services (IPS). Mr. Gilroy previously served as senior director, engineering. He will assume responsibility for the strategic direction and overall management of IPS’ construction division including construction management, program management, pre-construction and design/build services. Also, Edward J. Tannebaum, AIA assumes the role of president, for the new Strategic Planning Initiatives (SPI) entity, providing facilities management consulting services for technology-intense customers. SPI also offers owner representation, related program development and expert management consultation services.
   
“A key contributor for a number of years, John’s promotion is the result of his ability to think strategically and his track record of successfully delivering large, technically complex facilities on a global scale,” said Dave Goswami, P.E., president and chief operating officer, IPS. “John understands all aspects of a project, from concept development and engineering through construction and validation; offering creative and innovative solutions to help our clients succeed.”
   
Mr. Gilroy has more than 20 years of technical experience in providing project management, engineering and construction for the pharmaceutical, biotechnology, petrochemical and semi-conductor industries. He has expertise and focus within pharmaceutical manufacturing including oral solid dosage, sterile, aseptic, potent and cytotoxic projects.
   
Mr. Tannebaum has more than 35 years of design, facility management and construction experience. He has served in senior management roles at several major construction service firms and large pharmaceutical companies. Mr. Tannebaum has completed manufacturing, R&D and corporate headquarters projects ranging from Internationally Compliant Aseptic Filling, GMP solid dosage manufacturing and packaging, pilot plants, potent compound facilities, and critical support operations to major R&D labs, facilities, and upgrades.